CORE C: Clinical Resources Core This core will provide centralized recruitment of subjects with systemic lupus erythematosus, incomplete lupus erythematosus, and healthy controls for use in this Center of Research Translation. Dedicated personnel will be responsible for all aspects of subject enrollment into this CORT, including compliance with human subjects protection regulations. The Clinical Core will administer standardized clinical and epidemiological questionnaires and obtain the subject's medical history and laboratory information. The Core will process blood samples for use in these studies and will store DNA, RNA, serum, and plasma.
The Specific Aims of the Clinical Core are: 1. Recruitment of subjects with systemic lupus erythematosus, incomplete lupus syndromes, and healthy controls. 2. Collection of demographic, clinical, and epidemiological data with storage in a secure, confidential database. 3. Collection and storage of DNARNA, plasma, and serum for distribution to researchers in the CORT These activities will be carried out as part of the existing Dallas Regional Autoimmune Disease Registry in order to leverage the infrastructure that is already in place. By providing these services as a Core, the interaction with subjects will be more effective and economical, with greater quality control.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center (P50)
Project #
5P50AR055503-03
Application #
7941913
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2009-09-01
Project End
2012-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
3
Fiscal Year
2009
Total Cost
$143,076
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Strauß, Romy; Rose, Thomas; Flint, Shaun M et al. (2017) Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options. J Mol Med (Berl) 95:753-765
Orme, Jacob J; Du, Yong; Vanarsa, Kamala et al. (2016) Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. Clin Immunol 169:58-68
Du, Yong; Wu, Tianfu; Zhou, Xin J et al. (2016) Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis. Inflammation 39:1169-76
Solow, Elizabeth Blair; Vongpatanasin, Wanpen; Skaug, Brian et al. (2015) Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population. J Am Coll Cardiol 65:2669-2670
Arriens, Cristina; Hynan, Linda S; Lerman, Robert H et al. (2015) Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus. Nutr J 14:82
Min, So-Youn; Yan, Mei; Kim, Sang Bum et al. (2015) Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway. J Inflamm (Lond) 12:53
Davis, Laurie S (2015) BiP, From Putting Out Fires to Fanning the Flames in Rheumatoid Arthritis. Arthritis Rheumatol 67:1147-50
Xiao, Feng; Waldrop, Shar L; Bronk, Steve F et al. (2015) Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells. Purinergic Signal 11:347-59
Ireland, Sara J; Monson, Nancy L; Davis, Laurie S (2015) Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine 73:236-44
Huang, Qi-Quan; Perlman, Harris; Birkett, Robert et al. (2015) CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis. Nat Commun 6:7086

Showing the most recent 10 out of 42 publications